Natalia Misciattelli Mocenigo Soranzo

Natalia Misciattelli Mocenigo Soranzo has a diverse work experience in the biotechnology, healthcare, and consulting industries. Natalia is currently working as the Chief Executive Officer at AAVantgarde Bio since September 2022. Prior to this role, they served as a Board/Court member at The Fishmongers' Company since September 2016. Natalia also held the position of Chief Business Officer at NovalGen, a privately held immuno-oncology company, from January 2021 to September 2022.

Earlier in their career, Mocenigo Soranzo worked as the Senior Vice President of Strategy & Business Operations at Freeline Therapeutics Limited from September 2017 to December 2020. Natalia also gained extensive experience at PA Consulting Group, where they held multiple roles including Partner - Life Sciences & Analytics from April 2011 to September 2017, Managing Consultant - Life Sciences from April 2007 to April 2011, and Principal Consultant - Life Sciences from April 2005 to April 2007.

Prior to that, they served at GE Healthcare as a Finance & Corporate Development - Strategy & Portfolio Manager from September 2002 to March 2005. Natalia began their career as a Finance - Audit & Assurance Advisory Senior Analyst at Arthur Andersen Business Consulting from August 2000 to September 2002.

Mocenigo Soranzo's earlier experience includes working as a Biotechnology Research Scientist at INVE TECHNOLOGIES nv from August 1995 to August 2000. Overall, they have a strong background in leadership, strategy, business operations, and analytics in the life sciences industry.

Natalia Misciattelli Mocenigo Soranzo pursued their doctoral degree in Microbiology from 1996 to 2000 at the University of Wales, Bangor. Prior to that, they attended Marie Kruse between 1987 and 1993, although details regarding their degree and field of study are not provided.